Postoperative Urinary Retention After Sacrospinous Ligament Fixation:
The Impact of Pain, Analgesic Use, and Other Perioperative Factors
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Introduction:
• Postoperative urinary retention
(POUR) and discharge home with
a urinary catheter are significant
sources of distress for patients
and increase the risk of UTIs.
• Postoperative pain and analgesic
use have not been well explored
as risk factors.

Table 1. Postoperative pain and trial of void failure

Of the 218 patients identified, 142 met eligibility criteria and were included in the final analyses.
POUR occurred in 26.8% of patients. Demographic characteristics were similar between groups except for age, which was higher in the failed TOV group (68 vs. 71, p = 0.049).
Mean and highest verbal pain scores were not significantly different between the passed and failed TOV groups (2 vs. 3, p=0.236; highest: 6 vs. 6, p=0.394).
Patients were less likely to have POUR if they consumed more NSAIDs per hour postoperatively (60.15 vs. 0.0, p=0.038), and if NSAIDs were administered on a schedule (p=0.019).
Higher preoperative post-void residual (p = 0.002), greater anterior prolapse stage (p = 0.009), anterior as the leading-edge compartment (p = 0.052) and concomitant hysterectomy (p =
0.001) were associated with POUR.

Passed TOV
n = 103
• Assess whether pain & analgesic
use affect rates of POUR after
sacrospinous ligament fixation
(SSLF)
• Investigate other potential
perioperative risk factors for
POUR

Methods:
• Retrospective cohort study from
Jan ‘14 to Sep ‘21 at 5 hospitals

Mean hours between pain
4.9
(1.67,
17)
score recordings
Mean verbal pain score
2
[1,
4]
a
floor to TOV
Highest verbal pain score
6.00
[3,
8]
a
floor to TOV

Failed TOV
n = 38

Table 3. Perioperative characteristics and trial of void failure
P

Preoperative PVR (cc)
3 [2, 4]

0.236

6 [4, 8]

0.394

• Excluded: No overnight stay, no
pain scores or pain medication
administration recorded

Was acetaminophen
scheduled or PRN
prior to TOV?

• POUR = failed postoperative trial
of void (TOV)

NSAIDS per hour floor
60.15 ± [0, 109]
to TOV (mg/hr)

0.19 [0, 0.98]

0 [0, 1.67]

91.29
[41.61, 124.49]
Scheduled: 59
(56.7)
PRN: 35 (33.7)
Neither: 10 (9.6)

75.03 [48.19,
122.66]
Scheduled: 20
(52.6)
PRN: 16 (42.1)
Neither: 2 (5.3)
0.0 ± [0, 60]

0.944
0.606

0.594

0.038

• Primary outcome: impact of
mean and highest verbal pain
score on POUR

Were NSAIDs
scheduled or PRN
prior to TOV?

Scheduled: 26 (25) Scheduled: 2 (5.3)
PRN: 54 (51.9)
PRN: 24 (63.2)
0.019
Neither: 24(23.1) Neither: 12 (31.6)

• Secondary outcomes: impact of
pain medication on POUR and
identification of other potential
perioperative risk factors

Time from last opioid
to TOV (minutes)

205 [65, 450]
n = 56

Time from last
acetaminophen to
TOV (minutes)
Time from last NSAID
to TOV (minutes)

135 [60, 320]
n = 17

Failed TOV
n = 38

Conclusions:
P

Preoperative Characteristics

Table 2. Postoperative analgesics and trial of void failure
Passed TOV
Failed TOV
P
n = 104
n = 38

• Included: >18 years old,
underwent SSLF

Passed TOV
n = 104

Patient Characteristic

4.5 (1.68, 8.25)

Data represent mean (min, max), median [interquartile range (IQR)]
cOn a scale of one to ten as documented in the electronic medical record by
nursing staff

Oral MMEs floor to
TOV (mg/hr)
Acetaminophen floor
to TOV (mg/hr)

• Statistical analyses: MannWhitney U and Fisher’s Exact
tests. P-value of 0.05 for
significance.
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•
•
•
•
•

Objectives:

2 Donald

0.497

290 [110, 580]
n = 85

345 [180, 603]
n = 33

0.251

280 [220, 540]
n = 61

360 [10, 665]
n = 19

0.803

Data in columns represent median [IQR] or count (%)
Unless otherwise specified, n = 104 and n = 38 for variables under passed and
failed TOV, respectively. MME = morphine mg equivalents

43.20 ± 47.59
2 [0-3], n = 103
Mean = 1.88
3 [1-4], n = 103

Anterior prolapse stage
Overall prolapse stage

Anterior 59 (56.7)
Leading-edge compartmenta Apical = 6 (5.8)
Posterior = 39 (37.5)

122.55 ± 183.53
2 [1-4], n = 37
Mean = 2.38
3 [2-4], n = 37
Anterior = 29 (78.4)
Apical = 2 (5.4)
Posterior = 6 (16.2)
n = 37

0.002
0.009
0.359
0.052

Intraoperative Characteristics
Bilateral: 84 (82)
Unilateral or bilateral
Unilateral: 19 (18)
performed
n = 103
Mesh: 27 (26.2)
Graft: 48 (46.6)
Material used for SSLF
Suture only: 28 (27.2)
n = 103
Concurrent hysterectomy, Concurrent: 4 (3.8)
prior hysterectomy,
Prior: 64 (61.5)
hysteropexy
Hysteropexy: 36 (34.6)
Concurrent anterior repair Yes: 68 (65.4)
performed
No: 36 (34.6)
Concurrent posterior repair Yes: 90 (86.5)
performed
No: 14 (13.5)
Concurrent suburethral
Yes: 67 (64.4)
sling performed
No: 37 (35.6)
Estimated blood loss (cc)
163.22 ± 67.64
Operating room time
95.97 ± 27.48
(minutes, incision to end of
n = 79
procedure)
SSLF@

Bilateral: 34 (89)
Unilateral: 4 (11)

0.383

Mesh: 10 (26.3)
Graft: 23 (60.5)
Suture only: 5 (13.2)

0.182

Concurrent: 8 (21)
Prior: 24 (63.2)
Hysteropexy: 6 (15.9)
Yes: 30 (78.9)
No: 8 (21.1)
Yes: 30 (78.9)
No: 8 (21.1)
Yes: 24 (63.2)
No: 14 (36.8)
179.34 ± 66.83

112.57 ± 49.23
n = 28

0.001
0.179
0.398
0.95

0.119
0.235

Data in columns represent mean ± standard deviation, median [IQR], or count (%).
PVR = post-void residual
Unless otherwise specified, n = 104 and n = 38 for variables under passed and failed TOV,
respectively.
a If anterior and another compartment were both leading edges, the leading edge was considered
anterior

• Pain was not associated with POUR
after SSLF.
• Greater postoperative use and
scheduled administration of NSAIDs
were associated with lower rates of
POUR. This was not true for opioid or
acetaminophen use.
• POUR was associated with higher
preoperative PVR, greater anterior
prolapse stage, if the leading edge of
the prolapse was anterior, and if a
hysterectomy was performed
concurrently.
• Anti-inflammatory properties of some
pain medications may be beneficial
postoperatively in decreasing the risk
of POUR.
• Knowing the preoperative and
intraoperative characteristics
associated with POUR after SSLF can
help identify patients who are at
higher risk prior to surgery and may
inform counseling.

